FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
June 01, 2023 at 14:43 PM EDT
Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.
Photography by Christophe Tomatis